Key result
An eHealth intervention for AMI patients yielded a non-significant cost reduction of €471 per patient (P=.22) and significantly higher quality-adjusted life years (0.74 vs 0.69, P=.01) at one year.
Why the study?
Remote monitoring using smartphone-compatible wearables has been cited as a tool to reduce healthcare costs, but cost-utility evidence in acute myocardial infarction follow-up was needed.
Does an eHealth remote monitoring intervention improve quality of life and reduce costs compared to regular follow-up in patients with acute myocardial infarction?
RCT
1:1
Does an eHealth remote monitoring intervention improve quality of life and reduce costs compared to regular follow-up in patients with acute myocardial infarction?
Effect estimate: cost reduction €471 (95% CI -275 to 1217)
Absolute Event Rate: 2417% vs 2888%
p-value: p=0.22
An eHealth remote monitoring intervention for AMI patients significantly improved quality-adjusted life years and showed a trend toward reduced costs at one year compared to standard care.
Improves QALYs at comparable cost after AMI; extends RCT evidence for eHealth remote monitoring.
BACKGROUND Smartphone compatible wearables have been released on the consumers market, enabling remote monitoring. Remote monitoring is often named as a tool to reduce the cost of care. OBJECTIVE The primary purpose of this paper is to describe a cost-utility analysis of an eHealth intervention compared to regular follow-up in patients with acute myocardial infarction (AMI). METHODS In this trial, of which clinical results have been published previously, patients with an AMI were randomized in a 1:1 fashion between an eHealth intervention and regular follow-up. The remote monitoring intervention consisted of a blood pressure monitor, weight scale, electrocardiogram device, and step counter. Furthermore, two in-office outpatient clinic visits were replaced by e-visits. The control group received regular care. The differences in mean costs and quality of life per patient between both groups during one-year follow-up were calculated. RESULTS Mean costs per patient were €2417±2043 (US $2657±2246) for the intervention and €2888±2961 (US $3175±3255) for the control group. This yielded a cost reduction of €471 (US $518) per patient. This difference was not statistically significant (95% CI –€275 to €1217; P=.22, US $–302 to $1338). The average quality-adjusted life years in the first year of follow-up was 0.74 for the intervention group and 0.69 for the control (difference –0.05, 95% CI –0.09 to –0.01; P=.01). CONCLUSIONS eHealth in the outpatient clinic setting for patients who suffered from AMI is likely to be cost-effective compared to regular follow-up. Further research should be done to corroborate these findings in other patient populations and different care settings. CLINICALTRIAL ClinicalTrials.gov NCT02976376; https://clinicaltrials.gov/ct2/show/NCT02976376 INTERNATIONAL REGISTERED REPORT RR2-10.2196/resprot.8038
No takes yet. Share an insight, caveat, or question.
Treskes et al. (2021) conducted an RCT in Acute myocardial infarction (AMI). eHealth intervention (remote monitoring and e-visits) vs. Regular follow-up was evaluated on Mean costs per patient (cost reduction €471, 95% CI -275 to 1217, p=0.22). An eHealth intervention for AMI patients yielded a non-significant cost reduction of €471 per patient (P=.22) and significantly higher quality-adjusted life years (0.74 vs 0.69, P=.01) at one year.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: